Dravet Syndrome—a rare, catastrophic form of epilepsy—has long left families desperate for hope. But recent developments in China’s healthcare and pharmaceutical sectors suggest that the China Dravet Syndrome Market is turning a critical corner. From cutting-edge therapies to government-backed initiatives, China is emerging as a promising hub for rare disease...